· rebuilt nightly from public records
Signal Sheet
Headquartered in Mclean, Virginia, Retension Pharmaceuticals is a publicly listed pharmaceutical preparations company, founded 2023. It raised $12.3M in Apr 2025 and its filings name 3 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Eric Keller | SEC filing, Apr 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Michael Berendt | SEC filing, Apr 2025 | Technology and tooling decisions |
| Chief Technology Officer | Donald Olds | SEC filing, Apr 2025 | Technology and tooling decisions |
| Chief Executive Officer | Find with a free trial | Lakewave contact search | Signs off on new vendors; budget owner |
| Chief Financial Officer | Find with a free trial | Lakewave contact search | Approves spend after a raise |
| Chief Information Officer | Find with a free trial | Lakewave contact search | Owns IT and infrastructure vendors |
Officer or director change
New leadershipFiled to go public
CapitalEach with a title and the filing that names them, so the first call goes to the right desk.
PeopleThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 21, 2026 | Officer or director change | New leadership | SEC filing |
| Sep 18, 2026 | Filed to go public | Capital | SEC filing |
| Apr 22, 2025 | Raised $12.3M in equity from 98 investors | Capital | SEC filing |
Lakewave finds the right people at Retension Pharmaceuticals, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Retension Pharmaceuticals with a free trial →| Headquarters | Mclean, Virginia, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Founded | 2023, DE |
| Ownership | Listed company |
| Raise history | $12.3M (Apr 2025) |
| Lakewave Rising | 50 · 2 kinds of evidence · rank in Virginia after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Retension Pharmaceuticals reported a $12.3M equity raise to the SEC on Apr 22, 2025 with 98 investors.
The company's SEC filing, Apr 2025 names Eric Keller (Executive Officer) among its officers.
Mclean, Virginia, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.